- Home
- SNTI vs XWEL Comparison
SNTI vs XWEL Comparison
Compare SNTI & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- XWEL
- Stock Information
- Founded
- SNTI 2016
- XWEL 2006
- Country
- SNTI United States
- XWEL United States
- Employees
- SNTI N/A
- XWEL N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- XWEL Other Consumer Services
- Sector
- SNTI Health Care
- XWEL Consumer Discretionary
- Exchange
- SNTI Nasdaq
- XWEL Nasdaq
- Market Cap
- SNTI 10.4M
- XWEL 9.0M
- IPO Year
- SNTI N/A
- XWEL N/A
- Fundamental
- Price
- SNTI $4.41
- XWEL $1.52
- Analyst Decision
- SNTI Strong Buy
- XWEL
- Analyst Count
- SNTI 1
- XWEL 0
- Target Price
- SNTI $12.00
- XWEL N/A
- AVG Volume (30 Days)
- SNTI 7.0M
- XWEL 230.8K
- Earning Date
- SNTI 11-14-2024
- XWEL 11-14-2024
- Dividend Yield
- SNTI N/A
- XWEL N/A
- EPS Growth
- SNTI N/A
- XWEL N/A
- EPS
- SNTI N/A
- XWEL N/A
- Revenue
- SNTI N/A
- XWEL $33,833,000.00
- Revenue This Year
- SNTI $254.47
- XWEL $22.75
- Revenue Next Year
- SNTI $169.66
- XWEL N/A
- P/E Ratio
- SNTI N/A
- XWEL N/A
- Revenue Growth
- SNTI N/A
- XWEL 11.79
- 52 Week Low
- SNTI $1.52
- XWEL $1.26
- 52 Week High
- SNTI $16.94
- XWEL $2.70
- Technical
- Relative Strength Index (RSI)
- SNTI 52.77
- XWEL 49.81
- Support Level
- SNTI $4.62
- XWEL $1.26
- Resistance Level
- SNTI $5.96
- XWEL $2.00
- Average True Range (ATR)
- SNTI 1.63
- XWEL 0.15
- MACD
- SNTI -0.14
- XWEL 0.04
- Stochastic Oscillator
- SNTI 18.48
- XWEL 34.46
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About XWEL XWELL Inc.
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.